A Salute to Our Founding Editor-in-Chief Bramah N. Singh,MD,DPhil,DSc,FRCP

Fitzgerald JD Trials of discovery. Class III antiarrhythmic agents: serendipity or drug design? Dialogues Cardiovas Med . 2004;9(4):243-252.

Singh BN , Vaughan Williams EM The effect of amiodarone, a new antianginal drug, on cardiac muscle . Br J Pharmacol. 1970;39(4):657-667.

Singh BN Historical development of the concept of controlling cardiac arrhythmias by lengthening repolarization: particular reference to sotalol. Am J Cardiol. 1990;65(2):3A-11A.

Nademanee K. , Kannan R. , Hendrickson JA , Ookhtens M. , Kay I. , Singh BN Amiodarone-digoxin interaction: clinical significance, time course of development, potential pharmacokinetic mechanisms and therapeutic implications. J Am Coll Cardiol. 1984;4(1):111-116.

Nademanee K. , Feld G. , Hendrickson JA , Singh PN , Singh BN Electrophysiologic and antiarrhythmic effects of sotalol in patients with life-threatening ventricular tachyarrhythmias . Circulation. 1985;72(3):555-564.

Singh BN , Kehoe R. , Woosley RL , Scheinman M. , Quart B. and the Sotalol Multicenter Study Group. Multi-center trial of sotalol compared with procainamide in the suppression of inducible ventricular tachycardia: a double-blind randomized parallel evaluation. Am Heart J. 1995;129(1):87-97.

Wei Sun , Sarma JSM , Singh BN Electrophysiological effects of dronedarone (SR33589), a noniodinated benzofuran derivative, in the rabbit heart-comparison with amiodarone. Circulation. 1999;100(22):2276-2281.

Singh BN , Singh SN , Reda DJ , et al, and SAFE-T Investigators. Antiarrhythmic therapy in maintaining stability of sinus rhythm in atrial fibrillation-Sotalol Amiodarone Atrial Fibrillation Efficacy Trial (SAFE-T). A Veterans Affairs Cooperative Study. N Engl J Med. 2005;352(18):861-872.

Singh BN , Connolly SJ , Crijns JGM , et al, for the EUR-IDIS and ADONIS Investigators.Dronedarone for maintenance of sinus rhythm in atrial fibrillation or flutter. N Engl Med. 2007;357(10):987-999.

Heng MK , Norris RM , Peter CT , Nisbet HD , Singh BN The effects of glucose-insulin-potassium on experimental myocardial infarction in the dog. Cardiovasc Res. 1978 ;12(7):429-435.

Miura M. , Thomas R. , Ganz W. , et al. The effect of delay in propranolol administration on reduction of myocardial infarct size after experimental coronary artery occlusion in dogs. Circulation. 1979;59(6):1148-1157.

Chew CYC , Collett JT , Campbell C. , Kannan R. , Singh BN Beneficial effects of amiodarone pretreatment on early ischemic ventricular arrhythmias relative to infarct size and regional myocardial blood flow in the conscious dog. J Cardiovasc Pharmacol . 1982;4(6): 1028-1036.

Peter CT , Heng MK , Singh BN , et al. Failure of high dose propranolol to reduce experimental myocardial ischemic damage. Circulation. 1978;57(3):534-540.

Smith HJ , Singh BN , Norris RM , Nisbet HD , John MB , Hurley PJ The effect of verapamil on experimental myocardial ischemia with a particular reference to regional myocardial blood flow and metabolism. Aust N Zeal Med. 1977;7(2):114-121.

Singh BN , Chew CYC , Hecht H. , Collett J. , Ormiston J. Effects of intravenously administered verapamil on hemodynamic variables and ventricular function in acute myocardial infarction. Clin Invest Med. 1980; 3(1-2):73-80.

Heng MK , Norris RM , Singh BN , Partridge JP Prognosis in unstable angina. Br Heart J. 1976;38(9): 921-925.

Williams FM , Singh BN , Ambler PK , Dorrington R. The effects of propranolol, practolol and metoprolol on exercise-induced tachycardia in relation to plasma levels in man. Clin Exp Pharmacol Physiol . 1976;3(5):473-482.

Tzivoni D. , Allen HN , Singh BN Prinzmetal’s angina. Alternating ST-segment deviation in anterior and inferior electrocardiographic leads during the same episode of pain. Chest. 1980;77(5):691-693.

Hecht HS , Chew CYC , Burnam MH , Hopkins J. , Schnugg S. , Singh BN Verapamil in chronic stable angina: amelioration of pacing-induced abnormalities of left ventricular ejection fraction, regional wall motion, lactate metabolism and hemodynamics. Am J Cardiol. 1981;48(3):536-544.

Chew CYC , Brown GB , Singh BN , Wong M. , Pierce C. , Peterson R. Effects of verapamil on coronary hemodynamic function and vasomobility relative to its mechanism of antianginal action . Am J. Cardiol. 1983;51(5): 699-705.

Singh BN Why a new journal in cardiovascular pharmacology and therapeutics ? J Cardiovasc Pharmacol Ther. 1996;1(1):1-2.